港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

中医药概念

847.583

-12.619-1.47%

涨家数：1

跌家数：10

平家数：- -

市盈率：- -

高：859.875

开：859.639

低：845.693

收：860.202

成交量：2,531.23万

成交额：8,822.08万

市值：862.67亿

流通市值：599.37亿

数据加载中...

总览新闻资讯

《业绩》神威药业(02877.HK)全年纯利9.5亿人币升13.1% 派2026年第一次中期息43分人币

阿斯达克财经

“国产伟哥”光环褪去？白云山金戈去年少卖近800万片，已连续两年下滑，销售量最高时曾一年卖出超1亿片

每日经济新闻

迈威生物、剂泰科技、星环科技递表港交所；特步国际、康臣药业、快手公布2025年年度业绩丨港交所早参

每日经济新闻

“伟哥”产品集体遭遇中年危机：礼来转让产品权益、白云山连续两年下滑

每日经济新闻

中智药业(03737)公布2025年业绩权益持有人应占利润1729万元同比减少81.8%

百年老字号，左手拆分右手收购

康臣药业(01681)将于6月22日派发末期股息每股0.4港元

康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元同比增加18.41%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1606/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","market":"HK","secType":"PLATE","nameCN":"中医药概念","latestPrice":847.5832,"timestamp":1776052496599,"preClose":860.2018,"halted":0,"volume":25312285,"delay":0,"changeRate":-0.014669,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-12.618591,"latestTime":"04-13 11:55:05","open":859.6385,"high":859.8745,"low":845.69275,"amount":88220831,"amplitude":0.016487,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1776052800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776043800000,1776052800000],[1776056400000,1776067200000]],"pbRate":0.863773,"peRate":14.027413,"turnoverRate":0.001651,"increases":1,"decrements":10,"flats":0,"marketCap":86266903296,"floatMarketCap":59936905472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1606\",,,,,undefined,":{"symbol":"BK1606","high":859.8745,"amplitude":0.016487,"preClose":860.2018,"low":845.69275,"pbRate":"0.863773","latestPrice":847.5832,"volume":25312285,"delay":0,"open":859.6385,"prevYearClose":830.6915,"prevWeekClose":860.202,"prevMonthClose":810.955,"prevQuarterClose":810.955,"fiveDayClose":844.19,"twentyDayClose":853.05,"sixtyDayClose":876.861,"secType":"PLATE","market":"HK","turnoverRate":0.001651,"peRate":14.027413,"marketCap":86266903296,"floatMarketCap":59936905472,"timestamp":1776052496599,"nameCN":"中医药概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1606\",,,,undefined,":{"bkCode":"BK1606","up":1,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1606\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622149858","title":"《业绩》神威药业(02877.HK)全年纯利9.5亿人币升13.1% 派2026年第一次中期息43分人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2622149858","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622149858?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 12:01","pubTimestamp":1774584060,"startTime":"0","endTime":"0","summary":"神威药业公布截至去年12月底止全年业绩，营业额31.35亿元人民币(下同)，按年跌17%。纯利9.5亿元，按年升13.1%；每股盈利126分。派2026年第一次中期股息每股43分，连同2025年第二次中期股息每股11分，2025财政年度每股股息共派54分，派息率为42.9%。沽空资料截至 2026-03-26 16:25。)过往派息公布日期派息事项派息内容2025/08/27中期业绩股息：人民币 0.1100 2025/03/28末期业绩股息：人民币 0.3600 2024/08/29第二期中期业绩股息：人民币 0.1100 2024/03/28中期业绩股息：人民币 0.4300 AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250317145330304_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250317145330304_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513350/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1513350/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1606","02877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622901815","title":"“国产伟哥”光环褪去？白云山金戈去年少卖近800万片，已连续两年下滑，销售量最高时曾一年卖出超1亿片","url":"https://stock-news.laohu8.com/highlight/detail?id=2622901815","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622901815?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 09:44","pubTimestamp":1774575840,"startTime":"0","endTime":"0","summary":"在中国男性健康的隐秘角落里，一场持续二十余年的市场暗战，正迎来新的变局。直到2014年，白云山的金戈以国产首仿身份登场，用价格优势撕开了一道口子，将市场改写为“国产品牌主导、原研药退守”的新局面。万艾可是“伟哥”一词的源头。白云山年报显示，金戈当年销售额同比下降近两成，销售量下降超一成，库存激增近五成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-03-27/doc-inhskwec8387409.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-27/doc-inhskwec8387409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600332","BK1606","BK0070","BK0028","BK0097","BK1197","BK0188","BK0196","BK0096","BK1515","BK1521","BK0183","BK0175","BK0239","00874","BK1191","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893988","title":"迈威生物、剂泰科技、星环科技递表港交所；特步国际、康臣药业、快手公布2025年年度业绩丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893988","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622893988?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 02:31","pubTimestamp":1774549863,"startTime":"0","endTime":"0","summary":"NO.1迈威生物、剂泰科技、星环科技递表港交所据港交所3月25日消息，迈威（上海）生物科技股份有限公司-B（以下简称迈威生物，SH688062）、剂泰科技（北京）股份有限公司-P（以下简称剂泰科技）、星环信息科技（上海）股份有限公司（以下简称星环科技，SH688031）已向港交所递交上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686067484.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686067484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0359201612.USD","LU1719994722.HKD","BK1590","LU0307460666.USD","BK1606","LU0588546209.SGD","LU0348767384.USD","BK1512","LU1770034418.SGD","BK1610","BK1608","81024","BK1191","LU0572944931.SGD","LU1303224171.USD","LU1720050803.USD","LU0456827905.SGD","BK0231","LU2097828714.EUR","LU2097828631.EUR","LU1251922891.USD","BK1591","KSTmain","XTEPY","LU0348766576.USD","LU1166156734.SGD","BK0239","LU0463099449.HKD","LU0327786744.USD","01368","LU0359201885.HKD","LU1794554557.SGD","LU0702159699.USD","BK1575","BK1615","LU0051755006.USD","688062","LU0326950275.SGD","BK1095","LU1023057109.AUD","LU0244354667.USD","LU0211977185.USD","LU0359202008.SGD","LU0140636845.USD","LU1188198961.HKD","01024","LU2097828805.USD","LU2097828557.USD","LU0210526637.USD","01681","BK1502","BK1583","LU0702159343.USD","BK1168","LU0593848301.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622865417","title":"“伟哥”产品集体遭遇中年危机：礼来转让产品权益、白云山连续两年下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2622865417","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622865417?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 21:35","pubTimestamp":1774532139,"startTime":"0","endTime":"0","summary":"在中国男性健康的隐秘角落里，一场持续二十余年的市场暗战，正迎来新的变局。曾经，一粒蓝色小药片定义了一个时代。作为全球首款口服ED（勃起功能障碍）治疗药物，辉瑞的万艾可于1998年横空出世，2000年进入中国，从此“伟哥”一词成了这个品类的代名词。紧随其后，礼来的希爱力以“36小时长效”的差异化定位入局，与万艾可、拜耳艾力达形成外资三足鼎立的格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603263685921684.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603263685921684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2237443895.HKD","BK4007","LU2552382132.HKD","LU1551013342.USD","BK0097","SG9999014914.USD","IE00B4JS1V06.HKD","LU1551013425.SGD","SGXZ31699556.SGD","SG9999015945.SGD","LU2750360997.AUD","IE00B2B36J28.USD","LU2552382058.USD","LU1629891620.HKD","BK0175","LU2028103732.USD","LU1232071149.USD","LU0689472784.USD","LU1988902786.USD","BK0183","BK0012","LU0079474960.USD","LU0640476718.USD","LU2087625088.SGD","LU2237443382.USD","IE00BN29S564.USD","BK1197","LU2471134796.USD","IE00BJJMRY28.SGD","SG9999014898.SGD","IE00B4R5TH58.HKD","LU2089284900.SGD","LU0683600562.USD","LU0198837287.USD","LU2491049909.HKD","LU0354030438.USD","LU0471298694.HKD","LU2237438978.USD","LU0708995401.HKD","LU2462157665.USD","SG9999018865.SGD","LU0225283273.USD","LU2271345857.HKD","LU0456855351.SGD","LU0466842654.USD","LU0203201768.USD","LU2471134523.USD","LU0109394709.USD","BK0028","LU1323610961.USD","LU0256863902.USD","00874","LU2896262040.SGD","LLYX","LU1057294990.SGD","LU1868837300.USD","LU2168564222.USD","LU0882574139.USD","LU0823416689.USD","LU2417539215.USD","LU2602419157.SGD","LU0786609619.USD","600332","IE00BWXC8680.SGD","LU0787776722.HKD","LU2236285917.USD","LU2111349929.HKD","LU2324357040.USD","IE00BJJMRX11.SGD","LU1069344957.HKD","LU0354030511.USD","LU1548497426.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","BK4588","LU1983299246.USD","LU2746668974.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU0114720955.EUR","LU0106261372.USD","LU0882574055.USD","IE00BKDWB100.SGD","BK1521","LU1280957306.USD","LU2750360641.GBP","IE0001KFT4U8.USD","LU0058720904.USD","LU0943347566.SGD","LU1093756168.USD","LU2213496289.HKD","IE00B775H168.HKD","LU2471134879.HKD","SG9999001176.SGD","LLY","IE00BFSS8Q28.SGD","LU1804176565.USD","LU1127390331.HKD","LU2237443978.SGD","LU0823434583.USD","LU2237443465.HKD","BK0070","LU1868837136.USD","BK0239","IE00B1XK9C88.USD","LU2491050154.USD","BK4599","SG9999015952.SGD","LU2491050071.SGD","BK0096","LU1720051108.HKD","LU0210536198.USD","BK4533","LU0889565916.HKD","LU0234572021.USD","LU1712237335.SGD","LLII","LU0471298777.SGD","LU2237443622.USD","LU0256863811.USD","IE0004445015.USD","LU0823434740.USD","BK1606","LU2168564149.EUR","LU2456880835.USD","BK4581","LU0203202063.USD","LU1267930730.SGD","LU2746668461.USD","BK4585","LU2168564065.EUR","BK1515","LU1868836591.USD","IE00BK4W5L77.USD","LU0316494557.USD","SG9999013999.USD","IE00B1BXHZ80.USD","LU2112291526.USD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU2168563687.JPY","LU0385154629.USD","IE00B7KXQ091.USD","LU2471134952.CNY","LU2089984988.USD","IE00BFSS7M15.SGD","GB00BDT5M118.USD","LU0238689110.USD","LU1061106388.HKD","LU2063271972.USD","SG9999015986.USD","LU0061475181.USD","IE0005OL40V9.USD","LU0672654240.SGD","LLYZ","LU1868836914.USD","LU2361044865.SGD","LU0820562030.AUD","SG9999015978.USD","LU2023250330.USD","LU1035775433.USD","LU2211815571.USD","LU2468319806.SGD","SG9999018857.SGD","LU1917777945.USD","IE0002141913.USD","LU1145028129.USD","LU0006306889.USD","LU2756315664.SGD","IE0009355771.USD","LU0109391861.USD","LU0320765059.SGD","LU0122379950.USD","LU1064131342.USD","SG9999014880.SGD","LU0417517546.SGD","LU2360106947.USD","LU1974910355.USD","LU1366192091.USD","LU0158827948.USD","LU2023251221.USD","LU1023059063.AUD","LU0353189763.USD","LU2552382215.SGD","LU1720051017.SGD","ELIS","IE00BK4W5M84.HKD","LU2089283258.USD","IE00BKPKM429.USD","LU0353189680.USD","LU2023250504.SGD","SG9999017495.SGD","LU2264538146.SGD","IE00BJT1NW94.SGD","LU2361045086.USD","LU2756315318.SGD","SG9999001176.USD","LU0158827781.USD","LU2108987350.USD","LU2361044949.HKD","LU2168564495.EUR","LU0323591593.USD","BK4516","BK4534","BK0196","ELIL","LU1868836757.USD","IE0004445239.USD","LU2237443549.SGD","LU0097036916.USD","BK1191","LU0820561818.USD","LU1093756325.SGD","LU1291159041.SGD","IE00BJLML261.HKD","LU0320765992.SGD","LU0820561909.HKD","LU2106854487.HKD","SG9999014906.USD","LU0094547139.USD","LU1814569148.SGD","LU2357305700.SGD","LU0964807845.USD","LU0432979614.USD","BK0188","SGXZ51526630.SGD","LU0289739699.SGD","LU2265009873.SGD","LU2461242641.AUD","LU0266013472.USD","SGXZ81514606.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622863664","title":"中智药业(03737)公布2025年业绩 权益持有人应占利润1729万元 同比减少81.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622863664","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622863664?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 21:23","pubTimestamp":1774531381,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中智药业(03737)公布2025年业绩，收 益约17.37亿元，同比减少21.6%;公司权益持有人应占利润1729万元，同比减少81.8%;每股盈利0.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03737","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622883248","title":"百年老字号，左手拆分右手收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2622883248","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622883248?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 16:06","pubTimestamp":1774512408,"startTime":"0","endTime":"0","summary":"文｜《投资者网》蔡俊百年老字号同仁堂，在进退维谷中。对此，公司责令涉事企业的相关人员辞职。2018年，公司爆发“回收过期蜂蜜”事件，此后业绩下滑，原董事长被查。对此，2025年公司采取多轮变革，核心逻辑是收归利润。2025年前三季度，公司营业收入、归母净利润分别为133.08亿元、11.78亿元，各自同比下降3.7%、12.78%。站在该维度上，2025年以来公司启动的管理层换血、分拆上市、收购补链，或不只是对过去路径依赖的被动修复。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774448106841990535","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1191","BK0086","03613","BK0183","BK1515","BK0188","BK1606","BK0097","BK0239","LU1688375341.USD","600085","BK1583","BK0196","BK0113","01666","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622838695","title":"康臣药业(01681)将于6月22日派发末期股息每股0.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622838695","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622838695?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 12:38","pubTimestamp":1774499930,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业(01681)发布公告，该公司将于2026年6月22日派发末期股息每股0.4港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01681","VIG","BK1606","BK4588","BK4585","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622888014","title":"康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元 同比增加18.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888014","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888014?lang=zh_cn&edition=fundamental","pubTime":"2026-03-26 12:07","pubTimestamp":1774498066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康臣药业 发布截至2025年12月31日止年度业绩，该集团取得收入人民币34.17亿元，同比增加15.17%;公司权益股东应占溢利10.78亿元，同比增加18.41%;每股基本盈利1.27元，拟派发末期股息每股0.4港元。肾科药物的销售收入于2025年约为24.0亿元，较上年同比增长约20.3%，持续领跑肾病现代中成药品类。尿毒清颗粒海外拓展也颇有成效，成功登陆印尼市场并登上当地学术舞台。妇儿药物的销售收入于2025年为3.76亿元，较上年同比增长约 4.0%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣药业(01681)发布年度业绩，股东应占溢利10.78亿元 同比增加18.41%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":28,"code":"91000000","status":"200"}]}}